†These authors contributed equally.
Academic Editor: Celestino Sardu
Atrial fibrillation (AF) is one of the most common arrhythmias in medical practice. Diabetes mellitus (DM) is one of the independent risk factors for atrial fibrillation. The increased morbility of atrial fibrillation in diabetes mellitus is related to both structural and electrical remodeling of atrium. Based on studies of atrial electrophysiological changes in diabetes mellitus, this article focuses on the electrical remodeling of atrial cardiomyocytes, including remodeling of sodium channels, calcium channels, potassium channels and other channels, to provide the basis for the clinical management of antiarrhythmic drugs in diabetic patients with atrial fibrillation.
Atrial fibrillation (AF) is one of the most common arrhythmias in medical practice worldwide [1]. Traditionally, AF can be classified into five patterns: first diagnosed, paroxysmal, persistent, long-standing persistent and permanent AF [2]. AF patients have an increased risk of congestive heart failure and stroke, resulting in severe disability and death [3]. Diabetes mellitus (DM) is one of major hazard factors for AF [4, 5, 6]. Subclinical AF episodes occur frequently in type 2 diabetes mellitus (T2DM) patients and are associated with increased thromboembolic risk [7]. Moreover, treatment of AF appears to be more challenging in patients with DM. Outcomes of AF ablation are worse in patients with DM compared to the general population and arrhythmia recurrence is significantly higher in the DM group compared to the non-DM group [8, 9]. Both AF and DM are currently prominent global public health issues [10]. However, the underlying mechanisms of AF in DM have not been completely investigated.
DM predisposes to AF due to several factors, such as atrial remodeling, autonomic system dysfunction [11] and epigenetic regulation [12]. Atrial remodeling includes structural remodeling and electrical remodeling. Atrial structural remodeling was found in both type 1 and type 2 DM animal models [5, 13]. There are evidences demonstrating that DM is associated with disordered arrangement and higher cross-sectional areas of atrial cardiomyocytes, as well as increased interstitial fibrosis and inflammation [5]. Ultrastructural studies of DM cardiomyocytes also showed irregularly arranged myofibrils, degenerated Z-lines, and swollen, vacuolated mitochondria with fragmentation [14]. In addition to structural remodeling, investigators have studied the ionic mechanisms that underlie the electrical remodeling of AF in DM [15]. This article reviews the remodeling of ion channels in atrial myocytes with DM and their related mechanisms, so as to provide the basis for the clinical treatment of antiarrhythmic drugs used in patients with diabetic AF.
In previous studies, diabetic animals have shown a high susceptibility for induced AF, with a significantly higher incidence of AF and a longer AF duration after atrial burst stimulation [4, 5, 6, 16, 17, 18, 19, 20, 21, 22]. The electrocardiogram and electrophysiological parameters of diabetic animals have been reported in humans [23] and in different animal models [24]. Diabetic animals often show irregularities in atrial depolarization as P-wave prolongation and increased P-wave dispersion, leading to impulse generation or conduction abnormalities [24]. Lower heart rate (HR), prolonged rhythm-to-rhythm (RR) interval and similar Q wave-R wave-S wave (QRS) duration, onset of wave Q to the end of wave T (QT interval), QTc interval (corrected QTc interval) were observed in type 1 diabetic Sprague Dawley (SD) rats induced by streptozotocin (STZ) (6 weeks after treatment) [4]. No significant differences were found in sinus cardiac length (SCL), left atrial (LA) effective refractory period (LA-ERP), right atrial (RA) ERP (RA-ERP), inter atrial conduction time (IACT), RA-ventricular conduction time (RA-VCT) and LA-ventricular conduction time (LA-VCT) between control and diabetic groups. In contrast, the conduction velocity of atria was slower and conduction in homogeneity was notably increased in diabetic rats with a higher incidence of AF. In STZ-induced diabetic Wistar rats (8 weeks after treatment), IACT was longer, LA-ERP and RA-ERP were shorter than control rats [5]. However, no significant differences were observed in atrioventricular Wenckebach cycle length (AV-WCL) and HR. The incidence of AF was also increased in a type 2 DM (T2DM) animal model [16]. In high fat diet (HFD) and low dose STZ treated SD male rats, LA conduction velocity was significantly lower as shown by mapping images. The IACT was longer and SCL, AV-WCL, RA-ERP and LA-ERP were not statistically different [17]. In 20-week-old Zucker Diabetic Fatty (ZDF) rats, SCL, the time of sinus node recovery and corrected sinus node recovery were noteworthy longer than those in the control group [18]. The electrocardiogram (ECG) of T2DM model Goto-Kakizaki (GK) rats showed accelerated HR, irregular P waves, separation of QRS and P waves, and partial blockade of electrical conduction [25]. Atrial effective refractory period (AERP), duration of P-wave, and the time from the onset of the P wave until the R wave (PR interval) and RR interval were longer in db/db type 2 diabetic mice (16 and 20 weeks of age) [13]. In summary, abnormal electrophysiological parameters were observed in both type 1 and type 2 DM models, including chemically induced type 1 DM, metabolic type 2 DM with mild to medium pancreatic injury followed by diet induced insulin resistance , and genetically hyperglycemic animals (Table 1, Ref. [4, 5, 13, 16, 17, 18, 25]).
Diabetes mellitus type | Animal model | Atrial alterations in electrophysiological parameters | References |
Chemically induced T1DM | STZ-induced diabetic SD rats (6 weeks after treatment) | HR↓, RR interval↑, conduction velocity↓, conduction inhomogeneity↑ | [4] |
STZ-induced diabetic Wistar rats (8 weeks after treatment) | IACT↑, LA-ERP↓, RA-ERP↓ | [5] | |
Metabolic T2DM | HFD and low-dose STZ treatment SD rats | LA-CV↓, IA-CT↑ | [16] |
HFD and low-dose STZ treatment SD rats | IACT↑ | [17] | |
Genetically T2DM | 20-week-old ZDF rats | SCL↑, sinus node recovery time↑ and corrected sinus node recovery time↑ | [18] |
Goto-Kakizaki rats | HR↑, irregular P waves, separation of P and QRS waves | [25] | |
db/db diabetic mice (16 and 20 weeks old) | AERP↑, duration of P-wave↑, interval of PR↑, and interval of RR↑ | [13] | |
T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; STZ, streptozotocin; SD, Sprague Dawley; HFD, high fat diet; HR, heart rate; IACT, inter atrial conduction time; LA-ERP, left atrial-effective refractory period; RA-ERP, right atrial-effective refractory period; LA-CV, left atrial conduction velocity; SCL, sinus cardiac length; AERP, atrial effective refractory period. |
The abnormal electrophysiological parameters in diabetes are closely related to
the changes of action potentials (AP) in atrial myocytes. AP duration (APD)
occurs in diabetic animals with higher APD
The voltage-gated sodium channel current (I
In atrial myocytes of db/db mice [13], I
Sodium channels are activated during the depolarization phase and then rapidly
deactivated. However, some channels reopen as a late or persistent sodium current
(I
The voltage gated calcium channel is another important cation influx channel.
The L-type calcium current (I
In atrial myocytes of STZ-induced diabetes, the maximum current density of
I
There are several types of potassium channels in cardiomyocytes. It has been
reported that the main repolarizing potassium currents (I
Bohne et al. [13] found atrial I
There are numerous studies showing that small conductance calcium-activated
potassium channels (SK channels) play important roles in diabetic AF. The SK
channels have three isoforms including SK1 (K
Howarth et al. [37] evaluated gene expression in the sinoatrial node of GK rats and found hyperpolarization-activated cyclic nucleotide-gated channels (HCN) were downregulated. The reduction of HCN isoforms were also reduced in the sinoatrial node of diabetic rats induced with STZ injection, indicating HCN might be an important contributor to the dysfunction of sinoatrial node in DM [38]. mRNA and protein expressions of hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2) were reduced exclusively in the ventricles of STZ rats [39]. However, HCN2 expression in the atrium of STZ rats and H9c2 cells treated with high glucose were unchanged.
Higher protein expression levels of Na
AF contributes to increase morbidity and mortality, especially in the DM population. Rhythm control is important to treat AF [40] and catheter ablation is the most effective treatment for AF [2]. However, success rate of ablation in diabetic patients remains lower compared to the general population particularly for those with persistent AF [8]. This is likely due to the complex substrate of AF in patients with diabetes, which may be related to chronic inflammation [41], sarcoplasmic endoplasmic reticulum calcium ATPase (SERCA) levels [42] or epigenetics, such as altered expression of microRNA [12] in AF patients. Anti-inflammatory agents may reduce AF recurrence post ablation [41]. Selective microRNA therapy, by upregulation or downregulation by microRNA, may be used to treat AF to prevent cardiac structural and electrical remodeling [12]. Various remodeling of ion channels occurs in diabetes, including the sodium channels, calcium channels, potassium channels and others, resulting in abnormal electrophysiological parameters of the atrium and increases the incidence of AF (Fig. 1). However, how these ion channels are regulated in the diabetic atrium is not fully understood. Therefore, molecular mechanisms of atrial electrical remodeling in diabetes need to be further explored, which may provide new targets for prevention and treatment of AF in diabetes mellitus.
Overview of ion channels remodeling contributing to the action
potential alteration of the atrial myocytes in diabetes mellitus. In diabetes
mellitus, I
These should be presented as follows: LLQ and RXW designed the study. LLQ, XYLiu and XYLi participated in literature search and wrote the manuscript. FY provided help and advice on writing the manuscript. All authors read and approved the final manuscript.
Not applicable.
Not applicable.
This study was supported in part by grants from the National Natural Science Foundation of China (82000317 and 81770331), Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee (BJ2020018) and Research Foundation from Wuxi Health Commission for the Youth (Q202034).
The authors declare no conflict of interest.